Epicrispr Biotechnologies, Inc.
Clinical trials sponsored by Epicrispr Biotechnologies, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Experimental gene 'Silencer' therapy enters human testing for rare muscle disease Results expected Jul 2027 (estimated)